Plasmin bitches, Plasmin!

























Bayer has granted Bausch & Lomb an exclusive worldwide license to Bayer's Plasmin technology for use in ophthalmology.

A product derived from processed human plasma, the liquid portion of the blood, Plasmin may have potential for use in developing novel therapies for ocular conditions. Bayer is pursuing development of Plasmin in non-ocular indications where Plasmin could be used as a thrombolytic agent to dissolve blood clots in veins and arteries.

Bausch & Lomb will make milestone payments based on the development and registration progress, and pay ongoing royalties based on product sales. Further details of the agreement are confidential.

What milestones has B+L made so far???????